TY - JOUR
T1 - Angiopoietin-2, its soluble receptor Tie-2, and metabolic syndrome components in a population-based sample
AU - Lorbeer, Roberto
AU - Baumeister, Sebastian E.
AU - Dörr, Marcus
AU - Nauck, Matthias
AU - Grotevendt, Anne
AU - Schlesinger, Sabrina
AU - Teumer, Alexander
AU - Völzke, Henry
AU - Grabe, Hans Jörgen
AU - Wallaschofski, Henri
AU - Vasan, Ramachandran S.
AU - Lieb, Wolfgang
N1 - Publisher Copyright:
© 2016 The Obesity Society
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Objective: Since angiopoietin-2 (Ang-2) levels strongly correlate with cardiovascular mortality and subclinical cardiovascular disease, it was hypothesized that levels of Ang-2 and its soluble receptor (sTie-2) were associated with the metabolic syndrome (MetS) and individual MetS components. Methods: Within the population-based Study of Health in Pomerania, two sets of analyses were performed. First, Ang-2 and sTie-2 were related to the prevalence of MetS and its components cross-sectionally (n = 3,205). Second, the association between baseline Ang-2 and sTie-2 and incident MetS or longitudinal changes in its components in 1,295 individuals was investigated. Results: High Ang-2 levels (90th percentile), compared with low Ang-2 levels (10th percentile), were positively associated with MetS (OR: 1.78) and with the following MetS criteria: increased triglycerides, lower HDL cholesterol, and higher non-fasting glucose. Furthermore, high sTie-2 levels (90th percentile), compared with low levels (10th percentile), were positively related to MetS (OR: 1.58) and most of its components. However, Ang-2 and sTie-2 levels were not associated with incident MetS or longitudinal change in components of MetS. Conclusions: Ang-2 and sTie-2 levels were cross-sectionally associated with MetS and several of its components. However, Ang-2 and sTie-2 levels were not associated with incident MetS or changes in individual MetS components during follow-up.
AB - Objective: Since angiopoietin-2 (Ang-2) levels strongly correlate with cardiovascular mortality and subclinical cardiovascular disease, it was hypothesized that levels of Ang-2 and its soluble receptor (sTie-2) were associated with the metabolic syndrome (MetS) and individual MetS components. Methods: Within the population-based Study of Health in Pomerania, two sets of analyses were performed. First, Ang-2 and sTie-2 were related to the prevalence of MetS and its components cross-sectionally (n = 3,205). Second, the association between baseline Ang-2 and sTie-2 and incident MetS or longitudinal changes in its components in 1,295 individuals was investigated. Results: High Ang-2 levels (90th percentile), compared with low Ang-2 levels (10th percentile), were positively associated with MetS (OR: 1.78) and with the following MetS criteria: increased triglycerides, lower HDL cholesterol, and higher non-fasting glucose. Furthermore, high sTie-2 levels (90th percentile), compared with low levels (10th percentile), were positively related to MetS (OR: 1.58) and most of its components. However, Ang-2 and sTie-2 levels were not associated with incident MetS or longitudinal change in components of MetS. Conclusions: Ang-2 and sTie-2 levels were cross-sectionally associated with MetS and several of its components. However, Ang-2 and sTie-2 levels were not associated with incident MetS or changes in individual MetS components during follow-up.
UR - http://www.scopus.com/inward/record.url?scp=84988696744&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84988696744&partnerID=8YFLogxK
U2 - 10.1002/oby.21632
DO - 10.1002/oby.21632
M3 - Article
C2 - 27601273
AN - SCOPUS:84988696744
SN - 1930-7381
VL - 24
SP - 2038
EP - 2041
JO - Obesity
JF - Obesity
IS - 10
ER -